150 related articles for article (PubMed ID: 2679028)
1. Clinical significance of plasma lipid levels.
Brewer HB
Am J Cardiol; 1989 Oct; 64(13):3G-9G. PubMed ID: 2679028
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol and atherosclerosis: a contemporary perspective.
Kashyap ML
Ann Acad Med Singap; 1997 Jul; 26(4):517-23. PubMed ID: 9395824
[TBL] [Abstract][Full Text] [Related]
3. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and coronary risk factors of patients with low concentrations of serum low-density lipoprotein cholesterol and total cholesterol.
Lien WP; Lai LP; Hwang JJ; Lin JL; Chen JJ; Tsai KS
J Formos Med Assoc; 1998 Nov; 97(11):745-9. PubMed ID: 9872030
[TBL] [Abstract][Full Text] [Related]
5. Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery disease.
Miller M; Mead LA; Kwiterovich PO; Pearson TA
Am J Cardiol; 1990 Jan; 65(1):1-5. PubMed ID: 2294675
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hyperlipidemia.
Gotto AM
Am J Cardiol; 1986 May; 57(14):11G-16G. PubMed ID: 3521247
[TBL] [Abstract][Full Text] [Related]
8. The Prospective Cardiovascular Münster Study: prevalence and prognostic significance of hyperlipidemia in men with systemic hypertension.
Assmann G; Schulte H
Am J Cardiol; 1987 May; 59(14):9G-17G. PubMed ID: 3591673
[TBL] [Abstract][Full Text] [Related]
9. 2017 Taiwan lipid guidelines for high risk patients.
Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
[TBL] [Abstract][Full Text] [Related]
10. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
[TBL] [Abstract][Full Text] [Related]
11. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
[TBL] [Abstract][Full Text] [Related]
12. Rationale and design of the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterol.
Rubins HB; Robins SJ; Iwane MK; Boden WE; Elam MB; Fye CL; Gordon DJ; Schaefer EJ; Schectman G; Wittes JT
Am J Cardiol; 1993 Jan; 71(1):45-52. PubMed ID: 8420235
[TBL] [Abstract][Full Text] [Related]
13. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
[TBL] [Abstract][Full Text] [Related]
14. Diabetic dyslipidemia.
Kreisberg RA
Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
[TBL] [Abstract][Full Text] [Related]
15. Range of serum cholesterol values in the population developing coronary artery disease.
Kannel WB
Am J Cardiol; 1995 Sep; 76(9):69C-77C. PubMed ID: 7572691
[TBL] [Abstract][Full Text] [Related]
16. Association of low plasma high density lipoprotein (HDL)-cholesterol concentration with documented coronary artery disease in males with non-insulin dependent diabetes mellitus.
Fuh MM; Shieh SM
Horm Metab Res; 1987 Jun; 19(6):267-70. PubMed ID: 3623416
[TBL] [Abstract][Full Text] [Related]
17. Familial lipoprotein disorders and premature coronary artery disease.
Schaefer EJ; Genest JJ; Ordovas JM; Salem DN; Wilson PW
Atherosclerosis; 1994 Aug; 108 Suppl():S41-54. PubMed ID: 7802728
[TBL] [Abstract][Full Text] [Related]
18. Screening for dyslipidemia. Practice parameter.
Hostetter AL
Am J Clin Pathol; 1995 Apr; 103(4):380-5. PubMed ID: 7726130
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol guidelines, lipoprotein cholesterol levels, and triglyceride levels: potential for misclassification of coronary heart disease risk.
Laemmle P; Unger L; McCray C; Chalin M; Glueck CJ
J Lab Clin Med; 1989 Mar; 113(3):325-34. PubMed ID: 2926240
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
